Correlation Between Summit Midstream and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Summit Midstream and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Midstream and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Midstream and BioNTech SE, you can compare the effects of market volatilities on Summit Midstream and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Midstream with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Midstream and BioNTech.

Diversification Opportunities for Summit Midstream and BioNTech

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Summit and BioNTech is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Summit Midstream and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Summit Midstream is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Midstream are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Summit Midstream i.e., Summit Midstream and BioNTech go up and down completely randomly.

Pair Corralation between Summit Midstream and BioNTech

Considering the 90-day investment horizon Summit Midstream is expected to generate 2.59 times less return on investment than BioNTech. But when comparing it to its historical volatility, Summit Midstream is 1.49 times less risky than BioNTech. It trades about 0.06 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  8,800  in BioNTech SE on November 2, 2024 and sell it today you would earn a total of  3,288  from holding BioNTech SE or generate 37.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Summit Midstream  vs.  BioNTech SE

 Performance 
       Timeline  
Summit Midstream 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Midstream are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile primary indicators, Summit Midstream exhibited solid returns over the last few months and may actually be approaching a breakup point.
BioNTech SE 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.

Summit Midstream and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Summit Midstream and BioNTech

The main advantage of trading using opposite Summit Midstream and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Midstream position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Summit Midstream and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities